Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,261 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by suruchi, 01-28-2013, 04:37 AM
|
0 responses
733 views
0 reactions
|
Last Post
by suruchi
01-28-2013, 04:37 AM
|
||
|
Started by emerINF, 01-27-2013, 03:59 PM
|
0 responses
736 views
0 reactions
|
Last Post
by emerINF
01-27-2013, 03:59 PM
|
||
|
Started by MELEH, 01-24-2013, 06:04 PM
|
0 responses
775 views
0 reactions
|
Last Post
by MELEH
01-24-2013, 06:04 PM
|
||
|
Started by kosto, 01-21-2013, 11:42 AM
|
0 responses
945 views
0 reactions
|
Last Post
by kosto
01-21-2013, 11:42 AM
|
||
|
Started by maierpa, 01-20-2013, 09:29 AM
|
0 responses
1,593 views
0 reactions
|
Last Post
by maierpa
01-20-2013, 09:29 AM
|
||
|
Started by GMIX, 01-17-2013, 05:29 PM
|
0 responses
977 views
0 reactions
|
Last Post
by GMIX
01-17-2013, 05:29 PM
|
||
|
Started by godinn, 01-17-2013, 01:29 AM
|
0 responses
874 views
0 reactions
|
Last Post
by godinn
01-17-2013, 01:29 AM
|
||
|
Started by biofreak, 06-13-2011, 10:02 AM
|
13 responses
14,085 views
0 reactions
|
Last Post
by wanfahmi
01-16-2013, 06:28 AM
|
||
|
Started by mike123, 01-15-2013, 11:18 AM
|
0 responses
956 views
0 reactions
|
Last Post
by mike123
01-15-2013, 11:18 AM
|
||
|
Started by ronmatanza, 01-15-2013, 10:06 AM
|
0 responses
748 views
0 reactions
|
Last Post
by ronmatanza
01-15-2013, 10:06 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:23 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:23 AM
|
||
|
Started by SEQadmin2, 09-09-2026, 12:14 PM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
09-09-2026, 12:14 PM
|
||
|
Started by SEQadmin2, 09-09-2026, 11:33 AM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
09-09-2026, 11:33 AM
|